참고문헌
- Andersson AF, Lindberg M, Jakobsson H, et al (2008). Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One, 3, 2836. https://doi.org/10.1371/journal.pone.0002836
- Bik EM, Eckburg PB, Gill SR, et al (2006). Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA, 103, 732-7. https://doi.org/10.1073/pnas.0506655103
- Correa P, Haenszel W, Cuello C, et al (1975). Archer M. A model for gastric cancer epidemiology. Lancet, 2, 58-9.
- Correa P (1984). Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl, 104, 131-6.
- Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process-- First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 52, 6735-40.
- Cover TL, Blaser MJ (2009). Helicobacter pylori in health and disease. Gastroenterology, 136, 1863-73. https://doi.org/10.1053/j.gastro.2009.01.073
- Dixon MF, Neville PM, Mapstone NP, et al (2001). Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut, 49, 359-63. https://doi.org/10.1136/gut.49.3.359
- Franco AT, Israel DA, Washington MK, et al (2005). Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl Acad Sci USA, 102, 10646-51. https://doi.org/10.1073/pnas.0504927102
- Fox JG, Rogers AB, Ihrig M, et al (2003). Helicobacter pyloriassociated gastric cancer in INS-GAS mice is gender specific. Cancer Res, 63, 942-50.
- Fox JG, Kuipers EJ (2011). Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil. Gut, 60, 567-8. https://doi.org/10.1136/gut.2010.229286
- Garcia Rodriguez LA, Lagergren J, Lindblad M, et al (2006). Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut, 55, 1538-44. https://doi.org/10.1136/gut.2005.086579
- Geboes K, Dekker W, Mulder CJ, et al (2001). Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa. Aliment Pharmacol Ther, 15, 1819-26. https://doi.org/10.1046/j.1365-2036.2001.01105.x
- Graham DY, Opekun AR, Osato MS, et al (2004). Challenge model for Helicobacter pylori infection in human volunteers. Gut, 53, 1235-43. https://doi.org/10.1136/gut.2003.037499
- Hagiwara T, Mukaisho M, Ling ZQ, et al (2007). Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats. Dig Dis Sci, 52, 988-94. https://doi.org/10.1007/s10620-006-9415-7
- Hagiwara T, Mukaisho M, Nakayama T, et al (2011). Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori. Gut, 60, 624-30. https://doi.org/10.1136/gut.2010.207662
- Hagiwara T, Mukaisho M, Nakayama T, et al (2012). Experimental strategies for induction of gastric adenocarcinomas under long-term proton pump inhibitor administration and Helicobacter pylori infection. Asian Pac J Cancer Prev, 13, 3005-6 https://doi.org/10.7314/APJCP.2012.13.6.3005
- Havu N (1986). Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion, 35, 42-55. https://doi.org/10.1159/000199381
- Havu N, Mattsson H, Ekman L, et al (1990). Enterochromaffinlike cell carcinoids in the rat gastric mucosa following longterm administration of ranitidine. Digestion, 45, 189-95. https://doi.org/10.1159/000200245
- Hawkey CJ, Karrasch JA, Szczepanski L, et al (1998). Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med, 338, 727-34. https://doi.org/10.1056/NEJM199803123381105
- Hill M (1985). Normal and pathological microbial flora of the upper gastrointestinal tract. Scand J Gastroenterol Suppl, 111, 1-6.
- Honda S, Fujioka T, Tokieda M, et al (1998a). Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol, 33, 454-60.
- Honda S, Fujioka T, Tokieda M, et al (1998b). Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res, 58, 4255-9.
- IARC Monographs on the Evaluation of Carcinogen risk to humans: some industrial chemicals, (1994) No. 60, Lyon: International Agency for Research on Cancer.
- Kuipers EJ, Pena AS, Kamp GV, et al (1993). Seroconversion for Helicobacter pylori. Lancet, 342, 328-31. https://doi.org/10.1016/0140-6736(93)91473-Y
- Kuipers EJ, Uyterlinde AM, Pena AS, et al (1995). Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for longterm safety. Am J Gastroenterol, 90, 1401-6.
- Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al (1996). Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med, 334, 1018-22. https://doi.org/10.1056/NEJM199604183341603
- Lee A, Fox AJ, Otto G, et al (1990). A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology, 99, 1315-23. https://doi.org/10.1016/0016-5085(90)91156-Z
- Lee A, O'Rourke J, De Ungria MC, et al (1997). A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology, 112, 1386-97. https://doi.org/10.1016/S0016-5085(97)70155-0
- Li XX, Wong GL, To KF, et al (2009). Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One, 4, 7985. https://doi.org/10.1371/journal.pone.0007985
- Lofgren JL, Whary MT, Ge Z, et al (2011). Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology, 140, 210-20. https://doi.org/10.1053/j.gastro.2010.09.048
- Marshall BJ, Warren JR (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-15.
- Martinsen TC, Bergh K, Waldum HL (2005). Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol, 96. 94-102. https://doi.org/10.1111/j.1742-7843.2005.pto960202.x
- Matsumoto S, Washizuka Y, Matsumoto Y, et al (1997). Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection. J Med Microbiol, 46, 391-7. https://doi.org/10.1099/00222615-46-5-391
- Mattsson H, Havu N, Brautigam J, et al (1991). Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterol, 100, 311-9. https://doi.org/10.1016/0016-5085(91)90197-S
- Meikle DD, Taylor KB, Truelove SC, et al (1976). Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer patients before and after vagotomy. Gut, 17, 719-28. https://doi.org/10.1136/gut.17.9.719
- Mukaisho K, Hagiwara T, Nakayama T, et al (2014). Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD. World J Gastroenterol, 20, 11962-5. https://doi.org/10.3748/wjg.v20.i34.11962
- Nair PP, Kritchenvski D (1971). The Bile Acids: Chemistry, Physiology and Metabolism. Chemistry. New York: Plenum Press, 1.
- Orlando LA, Lenard L, Orlando RC, et al (2007). Chronic hypergastrinemia: causes and consequences. Dig Dis Sci, 52, 2482-9. https://doi.org/10.1007/s10620-006-9419-3
- Polk DB, Peek Jr RM (2010). Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer, 10, 403-14. https://doi.org/10.1038/nrc2857
- Shafaghi A, Mansour-Ghanaei F, Joukar F, et al (2013). Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac J Cancer Prev, 14, 3931-6. https://doi.org/10.7314/APJCP.2013.14.6.3931
- Stamp DH (2002). Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy. Med Hypotheses, 59, 398-405. https://doi.org/10.1016/S0306-9877(02)00125-1
- Sheh A, Fox JG (2013). The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes, 4, 505-31. https://doi.org/10.4161/gmic.26205
- Sordal O, Waldum H, Nordrum IS, et al (2013). The gastrin receptor antagonist netazepide (YF476) prevents oxyntic mucosal inflammation induced by Helicobacter pylori infection in Mongolian gerbils. Helicobacter, 18, 397-405. https://doi.org/10.1111/hel.12066
- Targownik LE, Metge CJ, Leung S, et al (2008). The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology. 134, 937-44. https://doi.org/10.1053/j.gastro.2008.01.010
- Tsukamoto H, Mizoshita T, Sasaki M, et al (2011). Longterm high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach. Asian Pac J Cancer Prev, 12, 1049-54.
- Uemura N, Okamoto S, Yamamoto S, et al (2001). Helicobacter pylori infection and the development of gastric cancer. Engl J Med. 345, 784-9. https://doi.org/10.1056/NEJMoa001999
- N. Wang TC, Fox JG (1998). Helicobacter pylori and gastric cancer: Koch's postulates fulfilled? Gastroenterol, 115, 780-3. https://doi.org/10.1016/S0016-5085(98)70159-3
- Wang TC, Dangler CA, Chen D, et al (2000). Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology, 118, 36-47. https://doi.org/10.1016/S0016-5085(00)70412-4
- Warren JR, Marshall BJ (1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1, 1273-5.
- Watanabe T, Tada M, Nagai H, et al (1998). S. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterol, 115, 642-8. https://doi.org/10.1016/S0016-5085(98)70143-X
- Watson SA, Grabowska AM, El-Zaatari M, et al (2006). Gastrin-active participant or bystander in gastric carcinogenesis? Nature Rev Cancer, 6, 936-46. https://doi.org/10.1038/nrc2014
- Worku ML, Karim QN, Spencer J, et al (2004). Chemotactic response of Helicobacter pylori to human plasma and bile. J Med Microbiol, 53, 807-11. https://doi.org/10.1099/jmm.0.45636-0
- Xu GP, Reed PI (1993). N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method. Carcinogenesis, 14, 2547-51. https://doi.org/10.1093/carcin/14.12.2547
- Yokota K, Kurebayashi Y, Takayama Y, et al (1991). Colonization of Helicobacter pylori in the gastric mucosa of Mongolian gerbils. Microbiol Immunol, 35, 475-80. https://doi.org/10.1111/j.1348-0421.1991.tb01577.x
- Ziebarth D, Spiegelhalder B, Bartsch H (1997). N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori. Carcinogenesis, 18, 383-9. https://doi.org/10.1093/carcin/18.2.383
피인용 문헌
- Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids vol.6, pp.1664-302X, 2015, https://doi.org/10.3389/fmicb.2015.00412
- 26695 to Identify Potential Virulence Factors vol.14, pp.3, 2016, https://doi.org/10.5808/GI.2016.14.3.125
- infection in pathogenesis of gastric carcinoma vol.7, pp.1, 2016, https://doi.org/10.4291/wjgp.v7.i1.97
- Proton pump inhibitors: Risks of long-term use vol.32, pp.7, 2017, https://doi.org/10.1111/jgh.13737